Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...

Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...

Illumina is at a pivotal moment, balancing near-term challenges with innovations in multiomics, AI, and proteomics to redefine its growth trajectory. ILMN's planned SomaLogic acquisition and new ...

NovaSeq X Transition Progress A key focus for Illumina continues to be the transition to its NovaSeq X platform, which is progressing according to plan. The company reported over 50 NovaSeq X ...

Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management ...

Illumina (ILMN) is capturing attention following the debut of its proprietary 5-base sequencing solution and impressive results from GeneDx’s pilot of the constellation platform. Both developments ...

At this year’s American Society of Human Genetics (ASHG) annual meeting, Illumina showcased its latest innovations designed to push the boundaries of genomic discovery and clinical research. Among ...

By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

The global AI in Biotechnology Market, valued at US$3.51000 million in 2024, stood at US$4,156.9 million in 2025 and is projected to ...

We applied swim flume-mediated exercise during zebrafish caudal fin regeneration to explore mechanical loading impacts on a robust model of organ regeneration. Exercise initiated during but not after ...